Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person After aberrantly dimerizing in response to epithelially expr...
| Class:Id | Summation:2060292 |
|---|---|
| _displayName | After aberrantly dimerizing in response to epithelially expr... |
| _timestamp | 2012-01-24 22:03:13 |
| created | [InstanceEdit:2060291] Rothfels, K, 2012-01-15 |
| modified | [InstanceEdit:2060778] Rothfels, K, 2012-01-16 [InstanceEdit:2065934] Rothfels, K, 2012-01-24 |
| text | After aberrantly dimerizing in response to epithelially expressed ligands, FGFR2b S252W and P253R mutants are assumed to undergo transautophosphorylation analagous to both the wild-type receptor, although this has not been explicitly demonstrated. Transformation of NIH 3T3 cells with the FGFR2b S252W mutant confers anchorage independent growth and results in increased phosphorylation of FRS2 in a manner that depends on a functional kinase domain (Dutt, 2008). Knock-down or chemical inhibition of other FGFR2-activating mutations identified in endometrial cancer cells has been shown to cause cell death (Byron, 2008). |
| (summation) | [Reaction:2033488] Autocatalytic phosphorylation of FGFR2b mutants with enhanced ligand binding [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by After aberrantly dimerizing in response to epithelially expr... (2060292)
